Depressive Symptoms in Spouses of HIV Infected Individuals: A Study of HIV Uninfected Caregivers in Pune, India
暂无分享,去创建一个
T. Marcotte | S. Mehendale | M. Ghate | Rachel Meyer | M. Sakamoto | H. Rangnekar | Hrishikesh Rangnekar
[1] E. Grouzmann,et al. Determination of catecholamines in plasma and urine. , 2013, Best practice & research. Clinical endocrinology & metabolism.
[2] Shauna P. Acquavita,et al. Utilization of communication technology by patients enrolled in substance abuse treatment. , 2013, Drug and alcohol dependence.
[3] M. Goniewicz,et al. Patterns of electronic cigarette use and user beliefs about their safety and benefits: an internet survey. , 2013, Drug and alcohol review.
[4] C. Halsted. B-Vitamin dependent methionine metabolism and alcoholic liver disease , 2013, Clinical chemistry and laboratory medicine.
[5] D. Ziedonis,et al. The New York policy on smoking in addiction treatment: findings after 1 year. , 2012, American journal of public health.
[6] C. Chiamulera,et al. Tobacco Addiction and Smoking Status in Heroin Addicts under Methadone vs. Buprenorphine Therapy , 2012, International journal of environmental research and public health.
[7] H. Amital,et al. Low serum vitamin D concentrations in patients with schizophrenia. , 2012, The Israel Medical Association journal : IMAJ.
[8] H. Knudsen,et al. Availability of nicotine replacement therapy in substance use disorder treatment: longitudinal patterns of adoption, sustainability, and discontinuation. , 2011, Drug and alcohol dependence.
[9] C. Schönfeldt-Lecuona,et al. Dysconnectivity of multiple resting-state networks in patients with schizophrenia who have persistent auditory verbal hallucinations. , 2011, Journal of psychiatry & neuroscience : JPN.
[10] J. Guydish,et al. Smoking prevalence in addiction treatment: a review. , 2011, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.
[11] B. Phillips,et al. Urine catecholamines in paediatrics , 2011, Archives of Disease in Childhood: Education & Practice Edition.
[12] M. Djalali,et al. Folate and vitamin B12 status in schizophrenic patients , 2011, Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences.
[13] K. Saulsgiver,et al. Contingency management for behavior change: applications to promote brief smoking cessation among opioid-maintained patients. , 2011, Experimental and clinical psychopharmacology.
[14] K. Olson,et al. Neurotransmitters excreted in the urine as biomarkers of nervous system activity: Validity and clinical applicability , 2011, Neuroscience & Biobehavioral Reviews.
[15] F. Abasiubong,et al. Assessing the psychological well-being of caregivers of people living with HIV/AIDS in Niger Delta region, Nigeria , 2011, AIDS care.
[16] D. Ziedonis,et al. Measuring smoking knowledge, attitudes and services (S-KAS) among clients in addiction treatment. , 2010, Drug and alcohol dependence.
[17] J. Tsoh,et al. Stopping smoking during first year of substance use treatment predicted 9-year alcohol and drug treatment outcomes. , 2010, Drug and alcohol dependence.
[18] G. Trachte,et al. Neurotransmitter testing of the urine: a comprehensive analysis , 2010, Open access journal of urology.
[19] P. Clayton,et al. Pyridoxal 5′‐phosphate deficiency causes a loss of aromatic l‐amino acid decarboxylase in patients and human neuroblastoma cells, implications for aromatic l‐amino acid decarboxylase and vitamin B6 deficiency states , 2010, Journal of neurochemistry.
[20] H. Knudsen,et al. Structural and Cultural Barriers to the Adoption of Smoking Cessation Services in Addiction Treatment Organizations , 2010, Journal of addictive diseases.
[21] G. Trachte,et al. Both stimulatory and inhibitory effects of dietary 5-hydroxytryptophan and tyrosine are found on urinary excretion of serotonin and dopamine in a large human population , 2009, Neuropsychiatric disease and treatment.
[22] K. Delucchi,et al. Staff Knowledge, Attitudes, and Practices regarding Nicotine Dependence Differ by Setting , 2009, Journal of drug issues.
[23] C. Yahne,et al. Smoking cessation during substance abuse treatment: what you need to know. , 2009, Journal of substance abuse treatment.
[24] D. Karnad,et al. COMPARISON OF ANXIETY, DEPRESSION AND POST-TRAUMATIC STRESS DISORDER IN THE RELATIVES OF CRITICALLY ILL PATIENTS IN AN AMERICAN AND INDIAN PUBLIC HOSPITAL , 2008 .
[25] P. Mottram,et al. Middle-ear disease and schizophrenia: case-control study. , 2008, The British journal of psychiatry : the journal of mental science.
[26] Antígona Martínez,et al. Magnocellular Pathway Impairment in Schizophrenia: Evidence from Functional Magnetic Resonance Imaging , 2008, The Journal of Neuroscience.
[27] Tobacco Use and Dependence Guideline Panel. Treating Tobacco Use and Dependence: 2008 Update , 2008 .
[28] P. Friedmann,et al. Cigarette smoking cessation services in outpatient substance abuse treatment programs in the United States. , 2008, Journal of substance abuse treatment.
[29] Jill M Williams. Eliminating tobacco use in mental health facilities: patients' rights, public health, and policy issues. , 2008, JAMA.
[30] S. Shiffman,et al. Use of smoking-cessation treatments in the United States. , 2008, American journal of preventive medicine.
[31] S. Shiffman,et al. Individual differences in adoption of treatment for smoking cessation: demographic and smoking history characteristics. , 2008, Drug and alcohol dependence.
[32] J. Guydish,et al. Staff Smoking and Other Barriers to Nicotine Dependence Intervention in Addiction Treatment Settings: A Review , 2007, Journal of psychoactive drugs.
[33] P Sham,et al. A diffusion tensor imaging study of structural dysconnectivity in never-medicated, first-episode schizophrenia , 2007, Psychological Medicine.
[34] S. Russell,et al. The psychometric properties of Beck Depression Inventory for adolescent depression in a primary-care paediatric setting in India , 2015 .
[35] F. Frankenburg. The Role of One‐Carbon Metabolism in Schizophrenia and Depression , 2007, Harvard review of psychiatry.
[36] I. Miller,et al. Relationship quality among HIV patients and their caregivers , 2007, AIDS care.
[37] K. Richter,et al. Cigarette smoking and interest in quitting in methadone maintenance patients. , 2006, Addictive behaviors.
[38] P. Pirraglia,et al. Coping and Burden Among Informal HIV Caregivers , 2006, Psychosomatic medicine.
[39] K. Richter,et al. A rationale and model for addressing tobacco dependence in substance abuse treatment. , 2006 .
[40] G. Fricchione,et al. Rapid screening for major depression in post-myocardial infarction patients: an investigation using Beck Depression Inventory II items , 2006, Heart.
[41] R. Garg,et al. Examining adherence and sexual behavior among patients on antiretroviral therapy in India , 2006 .
[42] D. Goff,et al. Dietary intake profile of patients with schizophrenia. , 2006, Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists.
[43] M. Stitzer,et al. Experimental evidence for a causal relationship between smoking lapse and relapse. , 2006, Journal of abnormal psychology.
[44] Lauren E Tobing,et al. Sustained Attention, Visual Processing Speed, and IQ in Children and Adolescents with Schizophrenia Spectrum Disorder and Psychosis Not otherwise Specified , 2005, Perceptual and motor skills.
[45] J. Bowman,et al. Smoking cessation interventions in Australian drug treatment agencies: a national survey of attitudes and practices. , 2005, Drug and alcohol review.
[46] P. Chandra,et al. HIV & psychiatric disorders. , 2005, The Indian journal of medical research.
[47] Melanie J Percy,et al. Disorders of oxidised haemoglobin. , 2005, Blood reviews.
[48] S. Hall,et al. A meta-analysis of smoking cessation interventions with individuals in substance abuse treatment or recovery. , 2004, Journal of consulting and clinical psychology.
[49] Won S. Choi,et al. Smoking cessation services in U.S. methadone maintenance facilities. , 2004, Psychiatric services.
[50] F. Hidalgo,et al. Determination of pyrrolized phospholipids in oxidized phospholipid vesicles and lipoproteins. , 2004, Analytical biochemistry.
[51] Rosemarie A. Martin,et al. Perceived barriers to quitting smoking among alcohol dependent patients in treatment. , 2003, Journal of substance abuse treatment.
[52] Mark Von Tress,et al. Generalized, Linear, and Mixed Models , 2003, Technometrics.
[53] Daniel Senkowski,et al. Frontal and Temporal Dysfunction of Auditory Stimulus Processing in Schizophrenia , 2002, NeuroImage.
[54] J. Mendelson,et al. An inpatient study of the effects of buprenorphine on cigarette smoking in men concurrently dependent on cocaine and opioids. , 2002, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.
[55] A. Iwanami,et al. Impaired cortical network for preattentive detection of change in speech sounds in schizophrenia: a high-resolution event-related potential study. , 2002, The American journal of psychiatry.
[56] S. Sussman. SMOKING CESSATION AMONG PERSONS IN RECOVERY , 2002, Substance use & misuse.
[57] J. Rapoport,et al. Children and adolescents with psychotic disorder not otherwise specified: a 2- to 8-year follow-up study. , 2001, Comprehensive psychiatry.
[58] John E. Roberts,et al. Meta-analysis of the relationship between HIV infection and risk for depressive disorders. , 2001, The American journal of psychiatry.
[59] M. Stein,et al. Interest in smoking cessation among injection drug users. , 2001, The American journal on addictions.
[60] K. Richter,et al. A Case for Addressing Cigarette Use in Methadone and Other Opioid Treatment Programs , 2000, Journal of addictive diseases.
[61] A. De,et al. An international study exploring levels of postpartum depressive symptomatology. , 2000, Journal of psychosomatic research.
[62] M. Jarvik,et al. Associations between tobacco smoking and illicit drug use among methadone-maintained opiate-dependent individuals. , 2000, Experimental and clinical psychopharmacology.
[63] C. Curtis,et al. Verbal working memory impairment in schizophrenia patients and their first-degree relatives: evidence from the digit span task. , 2000, The American journal of psychiatry.
[64] E. Hahn,et al. Smoking cessation in drug treatment programs. , 1999, Journal of addictive diseases.
[65] P. Männistö,et al. Catechol-O-methyltransferase (COMT): biochemistry, molecular biology, pharmacology, and clinical efficacy of the new selective COMT inhibitors. , 1999, Pharmacological reviews.
[66] Bao-Ming Li,et al. Alpha-2 Adrenergic Modulation of Prefrontal Cortical Neuronal Activity Related to Spatial Working Memory in Monkeys , 1999, Neuropsychopharmacology.
[67] P. Bossuyt,et al. Empirical evidence of design-related bias in studies of diagnostic tests. , 1999, JAMA.
[68] J. Gitlin,et al. The Role of Copper in Neurodegenerative Disease , 1999, Neurobiology of Disease.
[69] J. Savard,et al. Screening Clinical Depression in HIV-Seropositive Patients Using the Hospital Anxiety and Depression Scale , 1999, AIDS and Behavior.
[70] L. Sobell,et al. Alcohol abusers who want to quit smoking: implications for clinical treatment. , 1999, Drug and alcohol dependence.
[71] G. Simon,et al. Outcomes of recognized and unrecognized depression in an international primary care study. , 1999, General hospital psychiatry.
[72] Michael F. Green,et al. Hemispheric asymmetry in schizophrenia: a “dual deficits” model , 1999, Biological Psychiatry.
[73] V. Ravi,et al. Anxiety and depression among HIV-infected heterosexuals--a report from India. , 1998, Journal of psychosomatic research.
[74] B. Campbell,et al. Smoking cessation for clients in chemical dependence treatment. A demonstration project. , 1998, Journal of substance abuse treatment.
[75] M. Jarvik,et al. Interest in smoking cessation among methadone maintained outpatients. , 1998, Journal of addictive diseases.
[76] R. Brooner,et al. Smoking habits and attitudes in a methadone maintenance treatment population. , 1997, Drug and alcohol dependence.
[77] R. Weinshilboum,et al. Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. , 1996, Pharmacogenetics.
[78] L. Melton,et al. Mortality following inpatient addictions treatment. Role of tobacco use in a community-based cohort. , 1996, JAMA.
[79] S. Folkman,et al. Coping and mood during aids-related caregiving and bereavement , 1996, Annals of behavioral medicine : a publication of the Society of Behavioral Medicine.
[80] N. Breslow,et al. Statistics in Epidemiology : The Case-Control Study , 2008 .
[81] N. Volkow,et al. Inhibition of monoamine oxidase B in the brains of smokers , 1996, Nature.
[82] Alison T. O'Brien,et al. Psychiatric and physical morbidity effects of dementia caregiving: prevalence, correlates, and causes. , 1995, The Gerontologist.
[83] T. Patterson,et al. Psychiatric Morbidity Associated with Acquired Immune Deficiency Syndrome‐Related Grief Resolution , 1995, The Journal of nervous and mental disease.
[84] G. Simon,et al. Recognition, management, and outcomes of depression in primary care. , 1995, Archives of family medicine.
[85] S. Folkman,et al. Caregiver burden in HIV-positive and HIV-negative partners of men with AIDS , 1994 .
[86] D. Perkins,et al. Mood disorders in HIV infection: prevalence and risk factors in a nonepicenter of the AIDS epidemic. , 1994, The American journal of psychiatry.
[87] J. Schmitz,et al. The effects of high and low doses of methadone on cigarette smoking. , 1994, Drug and alcohol dependence.
[88] K. Nichol,et al. Effect of treatment for nicotine dependence on alcohol and drug treatment outcomes. , 1993, Addictive behaviors.
[89] D. Silverman. Psychosocial impact of HIV-related caregiving on health providers: a review and recommendations for the role of psychiatry. , 1993, The American journal of psychiatry.
[90] J. Bobo,et al. Recovering staff and smoking in chemical dependency programs in rural Nebraska. , 1993, Journal of substance abuse treatment.
[91] A. Procter,et al. Enhancement of Recovery from Psychiatric Illness by Methylfolate , 1991, British Journal of Psychiatry.
[92] G. Gerhardt,et al. Sensory physiology and catecholamines in schizophrenia and mania , 1990, Psychiatry Research.
[93] J. Bobo. Nicotine dependence and alcoholism epidemiology and treatment. , 1989, Journal of psychoactive drugs.
[94] J C Duffy,et al. Under-reporting of alcohol consumption in sample surveys: the effect of computer interviewing in fieldwork. , 1984, British journal of addiction.
[95] N W Daw,et al. The effect of norepinephrine on visual cortical neurons in kittens and adult cats , 1984, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[96] B. Bogin,et al. The relationship of socioeconomic status and sex to body size, skeletal maturation, and cognitive status of Guatemala City schoolchildren. , 1983, Child development.
[97] M. Hughes,et al. Chronic vitamin D deficiency in the weanling rat alters catecholamine metabolism in the cortex , 1982, Brain Research.
[98] M. Moore,et al. The effects of selected monopyrroles on various aspects of heme biosynthesis and degradation in the rat. , 1979, Archives of biochemistry and biophysics.
[99] D. Irvine. Pyrroles in neuropsychiatric and porphyric disorders: confirmation of a metabolite structure by synthesis. , 1978, Life sciences.
[100] U. Binswanger,et al. Parathyroid hormone responses to catecholamines and to changes of extracellular calcium in cows. , 1978, The Journal of clinical investigation.
[101] M. Levitt,et al. Catechol-O-Methyltransferase activity in psychotic children , 1976, Journal of autism and childhood schizophrenia.
[102] E. Eichner,et al. Effect of alcohol on serum folate level. , 1973, The Journal of clinical investigation.
[103] C. S. Russell. Biosynthesis of porphyrins and the origin of the "mauve factor". , 1972, Journal of theoretical biology.
[104] U. Ungerstedt,et al. Receptor activity and turnover of dopamine and noradrenaline after neuroleptics. , 1970, European journal of pharmacology.
[105] A. Sjoerdsma,et al. ELUCIDATION OF THE RATE-LIMITING STEP IN NOREPINEPHRINE BIOSYNTHESIS IN THE PERFUSED GUINEA-PIG HEART. , 1965, The Journal of pharmacology and experimental therapeutics.
[106] J. Overall,et al. The Brief Psychiatric Rating Scale , 1962 .
[107] B. Rudder. On the cause of growth acceleration , 1960 .
[108] J. Schmidt-Voigt,et al. Krankheitsdisposition und Entwicklungsbeschleunigung der Heutigen Jugend , 1940, Klinische Wochenschrift.
[109] H. E. Jones,et al. Mental-Physical Relationships during the preschool period , 1937 .
[110] O. Heubner. Das Nervöse kind , 1922, Klinische Wochenschrift.
[111] L. Eby,et al. Counselors' knowledge of the adoption of tobacco cessation medications in substance abuse treatment programs. , 2011, The American journal on addictions.
[112] S. Hall,et al. Cigarette smoking in opioid-using patients presenting for hospital-based medical services. , 2008, The American journal on addictions.
[113] R. Garg,et al. Adherence to antiretroviral therapy & its determinants amongst HIV patients in India. , 2008, The Indian journal of medical research.
[114] M. Reid,et al. Attitudes toward the integration of smoking cessation treatment into drug abuse clinics. , 2007, Journal of substance abuse treatment.
[115] D. Ziedonis,et al. Barriers and Solutions to Addressing Tobacco Dependence in Addiction Treatment Programs , 2006, Alcohol research & health : the journal of the National Institute on Alcohol Abuse and Alcoholism.
[116] J. Mendelson,et al. Buprenorphine effects on cigarette smoking , 2004, Psychopharmacology.
[117] J. Mendelson,et al. Effects of heroin self-administration on cigarette smoking , 2004, Psychopharmacology.
[118] K. Richter,et al. Tobacco use and quit attempts among methadone maintenance clients. , 2001, American journal of public health.
[119] D. Kalman. Smoking cessation treatment for substance misusers in early recovery: a review of the literature and recommendations for practice. , 1998, Substance use & misuse.
[120] J. Flaskerud,et al. Health problems of low-income female caregivers of adults with HIV/AIDS. , 1998, Health care for women international.
[121] R. Heinrichs,et al. Neurocognitive deficit in schizophrenia: a quantitative review of the evidence. , 1998, Neuropsychology.
[122] W. McCarthy,et al. Tobacco use as a distal predictor of mortality among long-term narcotics addicts. , 1994, Preventive medicine.
[123] M. Stephens,et al. Family health psychology. , 1992 .
[124] R. V. Lee,et al. The clinical picture , 1990 .
[125] L. Kozlowski,et al. Prospects for smoking treatment in individuals seeking treatment for alcohol and other drug problems. , 1989, Addictive behaviors.
[126] R. Griffiths,et al. Effects of methadone on human cigarette smoking and subjective ratings. , 1984, The Journal of pharmacology and experimental therapeutics.
[127] P. Korboot,et al. Auditory processing speed and signal detection in schizophrenia. , 1976, Journal of abnormal psychology.